Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

15:22 ET AAIC® 2019 Highlights New Research Showing Healthy Lifestyle May Offset Environmental and Genetic Risk of Alzheimer's Disease

Research presented at the Alzheimer's Association International Conference (AAIC) 2019 in Los Angeles suggests adopting multiple healthy lifestyle...


08:00 ET Inner Analytics Launches Computer Vision Technology for Personalized Food Prescriptions

Inner Analytics announced today the launch of its new computer vision technology that enables patients to conveniently and intuitively manage...


Jul 16, 2019, 09:00 ET Cognetivity Neurosciences' Chief Medical Officer to Present at Alzheimer's Association International Conference (AAIC) 2019

AAIC is the Largest and Most Influential International Meeting Dedicated to Advancing Dementia Science Cognetivity's Chief Medical Officer to Present ...


Jul 15, 2019, 16:11 ET Neovasc Participates in Round-Robin Study Evaluating In-Vitro Pulsatile Flow Testing of Prosthetic Heart Valves

Company Joined by Other Industry Leaders as Part of ISO Cardiac Valves Working Group NASDAQ, TSX: NVCN VANCOUVER, July 15, 2019 /CNW/ - Neovasc, Inc. ...


Jul 15, 2019, 12:30 ET Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias

Significant advances in the global search for blood test technologies for Alzheimer's disease and other dementias were reported at the Alzheimer's...


Jul 10, 2019, 07:00 ET Health Canada Approves Pomalyst®-Based Triplet Combination for Patients With Multiple Myeloma

POMALYST®, in combination with bortezomib and dexamethasone, provides a new medication option for patients living with multiple myeloma TORONTO, July ...


Jul 09, 2019, 07:30 ET ProMIS Neurosciences' Data for Alzheimer's Disease Clinical Candidate PMN310 Published in Scientific Reports

Nature Research Journal highlights data supporting the therapeutic potential of PMN310 against the toxic oligomer form of amyloid beta, a root cause...


Jun 28, 2019, 09:17 ET New Study Shows That Nut Consumption May Help Improve Erectile Function

A recent study, partially supported by the INC and published in the journal Nutrients1, observed a significant increase in erectile function after...


Jun 27, 2019, 08:55 ET Neovasc Announces Presentations on Tiara™ for Treatment of Mitral Regurgitation and Reducer™ for Treatment of Refractory Angina at the CSI Frankfurt 2019 Conference

NASDAQ, TSX: NVCN VANCOUVER, June 27, 2019 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX: NVCN), a leader in the development...


Jun 27, 2019, 07:30 ET ProMIS Neurosciences' PMN310 Shows Greater Therapeutic Potential vs. Other Amyloid-Beta-Directed Antibodies

Data presented at Keystone Symposium on Neurodegenerative Diseases TORONTO and CAMBRIDGE, MA, June 27, 2019 /CNW/ - ProMIS Neurosciences, Inc. (TSX:...


Jun 26, 2019, 08:15 ET ImmunoPrecise Guarantees Success for Customers of Their Well-Established B cell Select™ Antibody Discovery Platform

VICTORIA, June 26, 2019 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC PINK: IPATF), the industry leader in...


Jun 26, 2019, 07:00 ET MDNA55 Shows Promising Results in Models of Ovarian Cancer

Scientists at the NIH and FDA Demonstrate Impressive Synergy of MDNA55 with Interferons TORONTO and HOUSTON, June 26, 2019 /CNW/ - Medicenna...


Jun 21, 2019, 09:56 ET Tetra Bio-Pharma Inc. Announces Voting Results of 2019 Annual General and Special Meeting

ORLEANS, ON, June 21, 2019 /CNW Telbec/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in...


Jun 20, 2019, 14:09 ET Helius Medical Technologies to talk science behind PoNS™ device at Rehab Week

A breakthrough in the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury TORONTO, June 20, 2019 /CNW/ - Helius...


Jun 20, 2019, 09:00 ET Syqe Medical Receives Regulatory Approval to Release World's First Drug Delivery Device for Precise Dosing of Cannabis

Syqe Medical, a leading pharma-tech company, today announced the launch of the world's first pharmaceutical-grade metered-dose cannabis inhaler in...


Jun 20, 2019, 08:00 ET Definiens & Targos Innovation: AI-powered multiplex IHC biomarker analytic solutions for precision medicine

Definiens, a leading international Artificial Intelligence (AI)–based biomarker analysis and advanced data mining provider for immuno-oncology...


Jun 20, 2019, 08:00 ET Medicenna Presents New Preclinical Results For its IL-2 Superkine Platform, MDNA109

-Long Acting MDNA109 provides durable tumor control and strong memory response without further treatment when combined with checkpoint inhibitors...


Jun 20, 2019, 07:30 ET Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study

Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company, reported today that the U.S. Food and Drug Administration has...


Jun 19, 2019, 14:05 ET First-ever successful mind-controlled robotic arm without brain implants

A team of researchers from Carnegie Mellon University, in collaboration with the University of Minnesota, has made a breakthrough in the field of...


Jun 18, 2019, 08:30 ET Medicenna Presents Preliminary Top-Line Clinical Results from their Phase 2b Trial of MDNA55 in Recurrent Glioblastoma

-Disease control rate of up to 83% achieved; evidence of improved survival for patients TORONTO and HOUSTON, June 18, 2019 /CNW/ - Medicenna...


Jun 18, 2019, 05:00 ET New study finds 62% of business owners feel depressed at least once a week

Canadian Mental Health Association study supported by BDC takes pulse of entrepreneurs' well-being TORONTO and MONTREAL, June 18, 2019 /CNW Telbec/ - ...


Jun 17, 2019, 02:30 ET Elthera Awarded 2.5 M €Grant From Horizon 2020 Program

Elthera is pleased to announce that it has been awarded 2.5 M € through the Horizon 2020 programme. Horizon 2020 is the financial instrument...


Jun 14, 2019, 15:24 ET Lilly Presents Positive Results for Taltz® (ixekizumab) vs. Humira® (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis at the European Congress of Rheumatology

TORONTO, June 14, 2019 /CNW/ - Eli Lilly and Company announced today that the company will present positive findings from the Phase 3b/4...


Jun 13, 2019, 16:14 ET Canadian-Developed Treatment Slows Progression of Debilitating Neurodegenerative Disorder

The Lancet Neurology Publishes Findings That Also Have Implications for Treating Alzheimer's, Parkinson's Disease and Multiple Sclerosis TORONTO,...


Jun 13, 2019, 07:30 ET GT Biopharma GTB-1550

GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company developing GTB-1550, a novel multi-target bispecific drug conjugate therapy for ...